During their analysis, the exclusion criteria covered studies on the mRNA level of E-cadherin, methylation of E-cadherin, cell lines, gene databases, systematic reviews, meta-analyses, other tumor types, endometriosis, E-cadherin not related to ovarian cancer patients, animal models, and ovarian cancer cells isolated from tumors and tested in vitro. This evidence concerns the gene CDH1 and neoplasm.